68Ga-PSMA-R2 (Johns Hopkins University)

N/A

Report date: 2025/12/01 17:16:51

Base Information

Drug Name68Ga-PSMA-R2 (Johns Hopkins University)
Drug Alias NameN/A
ClassificationBiologicsRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68Ga +[5] 
Mechanisms of ActionIonising radiation emittersProstate-Specific Membrane Antigen binders
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdvanced Accelerator Applications Sa
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A